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PROSTAGLANDIN E 2 REGULATES THE LEVEL AND 
STABILITY OF CYCLOOXYGENASE-2 mRNA THROUGH 
ACTIVATION OF p38 MITOGEN-ACTIVATED PROTEIN 
KINASE IN INTERLEUKIN-I~-TREATED HUMAN SYNOVIAL 
FIBROBLASTS: Role of 3' untranslated region 
Wissam H. Faour, Yulan He, John A. Di Battista: 
Osteoarthritis Research Unit, HSpital Notre-Dame du CHUM, 
Montreal, (Qc), Canada. H2L 4M1 
The p38 mitogen-activated protein kinase (MAPK) mediates tran- 
scriptional and post-transcriptional control of cyclooxygenase- 
2 (COX-2) mRNA following IL-1/LPS cellular activation. We 
explored a positive feed-back, prostaglandin E 2 (PGE2)- 
dependent stabilization of COX-2 mRNA mediated by the p38 
MAP kinase cascade in IL-113 stimulated human synovial fibro- 
blasts (HSF). We observed a rapid (5 mm), massive (>30-fold), 
and sustained (>48h) increase in COX-2 mRNA, protein and PGE 2 
release following a rhlL-iB signal that was inhibited by NS-398, 
a COX-2 inhibitor, and SB202190, a selective, cell-permeable 
p38 MAP kinase inhibitor. PGE 2 completely reversed NS-398- 
mediated inhibition but not SB202 190-dependent inhibition. The 
eicosanoid didn't potentiate IL-II3-induced COX-2 expression nor 
did it activate COX-2 gene expression in quiescent cells. 
Transfection experiments with a human COX-2 promoter con- 
struct revealed a minor element of p38 MAP kinase-dependent 
transcriptional control after IL-I~ stimulation. P38 MAP kinase 
synergized with the cAMP/PKA cascade to transactivate the 
COX-2 promoter. When HSF were activated with rhlL-1 ~ for 3-4h 
(steady-state) followed by wash-out, the elevated levels of COX- 
2 mRNA declined rapidly (<2 h) to control levels. If PGE 2, unlike 
EP2/3 agonists butaprost and sulprostone, was added to fresh 
medium, COX-2 mRNA levels remained elevated for up to 16 h. 
SB202190 or anti-PGE 2 monoclonal antibody compromised the 
stabilization of COX-2 mRNA by PGE 2. Deletion analysis using 
transfected chimeric luciferaseCOX-2 mRNA 3'-UTR reporter 
constructs revealed that IL-IB increased reporter gene mRNA 
stability and translation via AU-containing distal regions of the 
UTR. This response was mediated entirely by a PGE2/p38 MAP 
kinase-dependent process. We conclude that the magnitude and 
duration of the induction of COX-2 mRNA, protein, and PGE 2 
release by rhlL-II3 is primarily the result of PGE2-dependent 
stabilization of COX-2 mRNA and stimulation of translation, a 
process involving a positive feedback loop mediated by the EP4 
receptor and the downstream kinases p38 MAPK and, perhaps, 
PKA. This study describes a new signaling paradigm for control 
of cytokine target genes. 
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OXIDATIVE MODIFICATION OF FIBRINOGEN AND 
FIBRONECTIN AS INITIAL STEP IN ADHESION FORMATION 
IN OSTEOARTHRITIC TEMPOROMANDIBULAR JOINTS 
LC Di!kgraaf, RSB Liem, FW Cordewener, G Zardeneta, 
LGM de Bont, SB Milam 
Groningen University Hospital, Groningen, The Netherlands, and 
University of Texas Health Science Center at San Antonio, USA 
Aim: The aim of this study was to investigate crosslinking of 
fibrinogen and fibronectin by free radicals, in order to test our 
hypothesis that free radicals contribute to the formation of 
crosslinked proteins that may serve as an initial scaffolding for 
developing adhesions frequently seen in osteoarthritic temporo- 
mandibular joints. 
Methods: Fibrinogen (1.2-12 ~.M) was incubated with thrombin 
(10 riM-6 ZM) or Fenton reagents, i.e. Fe(ll)SO 4 (25 ~.M-10 mM) 
and H202 (1.32 mM), to compare physiological clot formation 
with aggregation caused by free radicals. In addition, fibronectin 
(0.45 ~.M) was incubated with Fe(II)SO 4 (10 mM-I mM) and H20 2 
(1.32 mM). Protein aggregation was analyzed by spectrophoto- 
metric turbidity measurements, light scattering techniques, SDS- 
PAGE, and rotary shadowing. 
Results: Fibrinogen and fibronectin were shown to aggregate 
after free radical treatment, as detected by turbidity measure- 
ments and light scattering techniques. Using SDS-PAGE, both 
proteins were shown to degrade under low oxidative stress. 
Under high oxidative stress, however, fragments from these pro- 
teins were found to be covalently crosslinked, resulting in high 
molecular weight protein aggregates. The aggregation was 
shown to be at random with rotary shadowing. 
Conclusions: This study shows that free radicals cause oxidative 
modification of proteins creating an opportunity for the formation 
of intramolecular and intermolecular crosslinks by the formation 
of covalent bonds. This may stabilize protein aggregates render- 
ing them more resistant to degradation, ultimately leading to 
adhesion formation in affected joints. 
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FIBROBLASI GROWTH FACTOR-18 IS A TROPHIC FACTOR 
FOR MATURE CHONDROCYTES 
JL Ellsworth, EE Moore, A, Feldhaus, L Yao, K Waggle, 
SD Hughes, RJ Fernandes*, DR Eyre* 
ZymoGenetics, Inc. Seattle, WA and *Department of 
Orthopaedics, University of Washington School of Medicine, 
Seattle, WA, USA 
Aim: The aim of this study was to examine the ffects of Fgf18 on 
chondrocyte proliferation and matrix production in vivo and in 
vitro. 
Methods: Adenovirus-mediated transfer of Fgf18 into murine 
pinnae and addition of Fgf18 to primary cultures of adult articular 
chondrocytes were used to assess the effects of Fgf18 on chon- 
drocytes. In situ hydridization and RT-PCR were used to examine 
the expression of Fgf18 and Fgf receptors in adult human 
articular cartilage. 
Results: Expression of Fgf18 by adenovirus-mediated gene 
transfer in murine pinnae resulted in a significant increase in 
chondrocyte number. Chondrocytes were identified by staining 
with toluidine blue and a monoclonal antibody to type II collagen. 
The nuclei of these cells stained with antibodies to PCNA and 
FGF receptor (FGFR) 2. Addition of Fgf18 to the media of articu- 
lar chondrocytes in monolayer or micromass cultures increased 
the proliferation of these cells and their production of extra- 
cellular matrix. Expression of Fgf/8 and two of its high affinity 
receptors, Fgfr 3-(I//c) and Fgfr 2-(/I/c) was localized to chondro- 
cytes of human articular cartilage. 
Conclusions: Fgf18 can act as atrophic factor for elastic 
chondrocytes in vivo and articular chondrocytes cultured in vitro. 
Expression of Fgf18 and the genes for two of its receptors in 
chondrocytes uggests that Fgf18 may play an autocrine role in 
the biology of normal articular cartilage. 
